|
M.G. Pavlova
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
|
№11-12 / 2022
|
|
M.B. Antsiferov (1), T.P. Nikitina (2), A.Yu. Rodionova (3), K.A. Kurbatova (2), T.I. Ionova (2)
HYPOGLYCEMIA AND QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№17 / 2015
|
|
M.B. Antsiferov
CLINICAL INERTIA IN THE THERAPY OF TYPE 2 DIABETES MELLITUS
|
№5 / 2015
|
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
E.E.Arinina, M.A.Rasheed, M. B. Antsiferov
Pharmacoeconomic Analysis Of Advantages Of Combined Incretin Therapy In Patients With Type 2 Diabetes Mellitus By The Example Of Vildagliptin
|
№5 / 2013
|
|
A.S.Ametov 1, N.K.Kulidzhanyan 1, I.V.Shurupova 2, T.A.Trifonova 2, M. B. Antsiferov 3
Effect Of Dipeptidyl Peptidase-4 Inhibitors On The Functional State Of Myocardium In Patients With Type 2 Diabetes Mellitus
|
№10 / 2012
|
|
M.B. Antsiferov 1, A.S. Ametov 2, A.V. Zilov 3
Dpp-4 Inhibitors: Today And Tomorrow. What We Expect From Incretin-stimulating Therapy?
|
№7 / 2012
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
|
M.B. Antciferov
Dipeptidyl Peptidase-4 Inhibitors - New Potentials For Treatment Of Type 2 Diabetes Mellitus: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№16 / 2011
|
|
Anciferov M.B.
Clinical Aspects For Use Of Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Benefits For Different Groups Of Patients
|
№3 / 2011
|
Русский
